Search research articles

お問い合わせ

JoVEについて

概要リーダーシップブログ JoVEヘルプセンター

著者向け

出版プロセス編集委員会範囲と方針査読よくある質問投稿

図書館員向け

推薦の声購読アクセスリソース図書館諮問委員会よくある質問

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments アーカイブ

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教員リソースセンター教員サイト

プライバシーポリシー

関連する概念動画

Classification of Skeletal Muscle Relaxants

Classification of Skeletal Muscle Relaxants

Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...

Clearance Models: Physiological Models

Clearance Models: Physiological Models

Drug clearance is a critical pharmacokinetic process involving the irreversible removal of drugs from the body through various organs over a specified time period. Physiological models are indispensable in determining organ-specific clearance, defined by the proportion of the drug eliminated per unit of time from the organ's blood volume.
The organ's clearance rate depends on the blood flow to the organ and the extraction ratio (E). The extraction ratio describes the organ's proficiency in drug...

Clearance Models: Compartment Models

Clearance Models: Compartment Models

Clearance measures drug elimination from the central compartment, including plasma and highly perfused organs like kidneys and liver. Its calculation varies depending on pharmacokinetic models and administration routes. The one-compartment model, for instance, portrays the pharmacokinetics of polar drugs such as aminoglycoside antibiotics administered intravenously and readily excreted in urine. In this case, clearance is influenced by the terminal rate constant (λz) and the total volume of...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え

Same author

Elimination of myotonia improves myopathy in a muscleblind-like knockout model of myotonic dystrophy.

Nature communications·2026

Same author

A Phase 1 Study of Convection-Enhanced Delivery of Intraputaminal AAV2-GDNF in Advanced Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026

Same author

AAV-Delivered RNAi Targeting Mutant LDB3 Prevents and Reverses Myofibrillar Myopathy through Mechanosignaling Restoration.

bioRxiv : the preprint server for biology·2026

Same author

WATER reveals heterochrony of molecular programs underlies developmental failure caused by minor spliceosome inhibition.

bioRxiv : the preprint server for biology·2026

Same author

Longitudinal Psychometric Properties of the Myotonic Dystrophy Health Index in a Large Multicenter Cohort of People Living With Myotonic Dystrophy Type 1.

Muscle & nerve·2026

Same author

SHAPE-MaP-Based Assessment of the Structure of Citrus Tristeza Virus Long Non-Coding RNA.

Viruses·2026

Search research articles

関連する実験動画

Updated: Jul 8, 2026

Tibial Nerve Transection - A Standardized Model for Denervation-induced Skeletal Muscle Atrophy in Mice

Tibial Nerve Transection - A Standardized Model for Denervation-induced Skeletal Muscle Atrophy in Mice

Published on: November 3, 2013

ミオトニック・ディストロフィーの筋肉盲のノックアウトモデル

Rahul N Kanadia¹, Karen A Johnstone, Ami Mankodi

¹Department of Molecular Genetics and Microbiology, Powell Gene Therapy Center, Gainesville, FL 32610, USA.

Science (New York, N.Y.)

|December 13, 2003

まとめ

ミオトニク・ディストロフィー (DM) は,繰り返された膨張から生じる. マウスのMbnl1遺伝子の破壊はDMのような症状を引き起こし,RNA配列化仮説を支持した.

さらに関連する動画

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

Rodent Model of Masseter Volumetric Muscle Loss for Studying Bioengineering Materials

Rodent Model of Masseter Volumetric Muscle Loss for Studying Bioengineering Materials

Published on: May 31, 2024

関連する実験動画

Last Updated: Jul 8, 2026

Tibial Nerve Transection - A Standardized Model for Denervation-induced Skeletal Muscle Atrophy in Mice

Tibial Nerve Transection - A Standardized Model for Denervation-induced Skeletal Muscle Atrophy in Mice

Published on: November 3, 2013

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

Rodent Model of Masseter Volumetric Muscle Loss for Studying Bioengineering Materials

Rodent Model of Masseter Volumetric Muscle Loss for Studying Bioengineering Materials

Published on: May 31, 2024

科学分野:

遺伝学遺伝学とは
分子生物学は分子生物学である.
神経筋疾患神経筋疾患

背景:

ミオトニック・ディストロフィー (Myotonic dystrophy,DM) は,遺伝的な神経筋肉疾患である.
それは,特定の遺伝子のマイクロサテライトの繰り返し拡張によって特徴付けられます.
DM患者の異常なRNAトランスクリプトは,RNA結合タンパク質を隔離し,スプライシングを妨げます.

研究の目的:

DMの病原性における筋肉盲似1 (Mbnl1) 遺伝子の役割を調査する.
Mbnl1の障害がDM疾患の特徴を再現するかどうかを判断する.
DMにおけるRNAセクエストレーションメカニズムの証拠を提供すること.

主な方法:

マウスモデルでのMbnl1の遺伝子破壊.
筋肉,眼,RNAスプライシングの異常を分析する.
Mbnl1欠乏マウスのフェノタイプとヒトのDMの比較.

主要な成果:

機能的なMbnl1が欠けていたマウスは,筋肉と目の異常を示した.
DMの特徴であるRNAスプライシングの欠陥は,Mbnl1欠乏したマウスで観察されました.
これらの発見は,Mbnl1とDMの病理学を直接関連付けています.

結論:

Mbnl1遺伝子は,正常な筋肉と目の発達に不可欠です.
Mbnl1の破壊は,ミオトニック・ディストロフィーを反映した疾患のフェノタイプにつながります.
変異RNAによるMbnlタンパク質の結合は,DMを駆動する重要なメカニズムである.